Literature DB >> 8194900

Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9.

N Kohno1, Y Inoue, H Hamada, S Fujioka, S Fujino, A Yokoyama, K Hiwada, N Ueda, M Akiyama.   

Abstract

KL-6 classified as Cluster 9 (MUC-I) is a circulating high-molecular-weight mucin-like molecule. Serum level of KL-6 was measured by a sandwich assay using KL-6 antibody as not only a catcher but also as a tracer. We established 2 additional monoclonal antibodies (MAbs), LISA 101 and EH-123, reacting with KL-6 epitopes different from the epitope recognized by KL-6 antibody. The KL-6-associated mucins detected by the sandwich assay using LISA 101 or EH-123 antibody as a catcher and KL-6 antibody as a tracer were designated as LISA 1-6 and CAM 123-6 respectively. The diagnostic values as the serum markers of KL-6, LISA 1-6 and CAM 123-6 were evaluated measuring their levels in the same serum from healthy individuals and from patients with pulmonary, pancreatic and breast adenocarcinomas. KL-6 was increased abnormally at high rates of more than 50% in pancreatic cancer and in benign lung diseases, LISA 1-6 only in pancreatic cancer, and CAM 123-6 only in pulmonary adenocarcinoma. In benign lung diseases, however, LISA 1-6 and CAM 123-6 were increased abnormally at the rates of only 5.3% and 0% respectively. These observations clearly indicate that LISA 1-6 and CAM 123-6 constitute a part of KL-6, but that they are superior to KL-6 as tumor markers for pancreatic cancer and for pulmonary adenocarcinoma respectively, because of their much lower false-positive rates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194900     DOI: 10.1002/ijc.2910570717

Source DB:  PubMed          Journal:  Int J Cancer Suppl        ISSN: 0898-6924


  15 in total

1.  Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation.

Authors:  T Ashida; M Higashishiba; Y Sumimoto; T Sano; H Miyazato; T Shimada; J Miyatake; K Kawanishi; Y Tatsumi; A Kanamaru
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

2.  Comparison of pulmonary thin section CT findings and serum KL-6 levels in patients with sarcoidosis.

Authors:  K Honda; F Okada; Y Ando; H Mori; K Umeki; H Ishii; J Kadota; M Ando; E Miyazaki; T Kumamoto
Journal:  Br J Radiol       Date:  2010-11-02       Impact factor: 3.039

3.  Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.

Authors:  Huan-Li Xu; Xin Zhao; Ke-Ming Zhang; Wei Tang; Norihiro Kokudo
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Circulating KL-6 levels in patients with drug induced pneumonitis.

Authors:  H Ohnishi; A Yokoyama; Y Yasuhara; A Watanabe; T Naka; H Hamada; M Abe; K Nishimura; J Higaki; J Ikezoe; N Kohno
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

5.  Radioimmunoscintigraphy of pancreatic cancer in tumor-bearing athymic nude mice using (99m)technetium-labeled anti-KL-6/MUC1 antibody.

Authors:  Kenji Matsumura; Ichiro Niki; Hui Tian; Masahisa Takuma; Norio Hongo; Shunro Matsumoto; Hiromu Mori
Journal:  Radiat Med       Date:  2008-04

6.  Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.

Authors:  Masaki Tomita; Takanori Ayabe; Eiichi Chosa; Naohiro Nose; Kunihide Nakamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-08-11

7.  Immunohistochemical and immunoelectron microscopic studies of the localization of KL-6 and epithelial membrane antigen (EMA) in presumably normal pulmonary tissue and in interstitial pneumonia.

Authors:  Yuji Ohtsuki; Jiro Fujita; Yasuki Hachisuka; Masashi Uomoto; Yuhei Okada; Takeo Yoshinouchi; Gang-Hong Lee; Mutsuo Furihata; Nobuoki Kohno
Journal:  Med Mol Morphol       Date:  2007-12-21       Impact factor: 2.309

8.  Diagnostic value of KL-6 in idiopathic interstitial pneumonia.

Authors:  Peiyan Zheng; Xiaoqing Liu; Huimin Huang; Zijun Guo; Ge Wu; Haisheng Hu; Chuanxu Cai; Wenting Luo; Nili Wei; Qian Han; Baoqing Sun
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

9.  Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease.

Authors:  Shigeo Kawase; Noboru Hattori; Nobuhisa Ishikawa; Yasushi Horimasu; Kazunori Fujitaka; Osamu Furonaka; Takeshi Isobe; Seigo Miyoshi; Hironobu Hamada; Takashi Yamane; Akihito Yokoyama; Nobuoki Kohno
Journal:  Respir Res       Date:  2011-07-26

10.  Distinct Cytoplasmic Expression of KL-6 Mucin in Chromophobe Renal Cell Carcinoma: A Comparative Immunohistochemical Study with Other Renal Epithelial Cell Tumors.

Authors:  Mana Fukushima; Kayoko Higuchi; Hisashi Shimojo; Takeshi Uehara; Hiroyoshi Ota
Journal:  Acta Histochem Cytochem       Date:  2012-09-11       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.